Enforcing intellectual property rights can be a challenging affair, and this is particularly true in the biotech industry. Attorneys Seth Northrop and Matt McFarlane discuss the issues facing biotech patent holders today, touching on subjects that include the importance of patent enforcement and injunctions, an appraisal of the current legal landscape and advice for biotech companies looking to enforce their own patent portfolio.
Press CTRL+C to copy embed code to clipboard